Details for New Drug Application (NDA): 040663
✉ Email this page to a colleague
The generic ingredient in WARFARIN SODIUM is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.
Summary for 040663
Tradename: | WARFARIN SODIUM |
Applicant: | Zydus Pharms Usa |
Ingredient: | warfarin sodium |
Patents: | 0 |
Pharmacology for NDA: 040663
Mechanism of Action | Vitamin K Inhibitors |
Suppliers and Packaging for NDA: 040663
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040663 | ANDA | Zydus Lifesciences Limited | 65841-052 | 65841-052-01 | 100 TABLET in 1 BOTTLE (65841-052-01) |
WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040663 | ANDA | Zydus Lifesciences Limited | 65841-052 | 65841-052-10 | 1000 TABLET in 1 BOTTLE (65841-052-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | May 30, 2006 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | May 30, 2006 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 30, 2006 | TE: | AB | RLD: | No |
Complete Access Available with Subscription